Dr. Brendan Connell
Claim this profileLahey Hospital and Medical Center
Studies Prostate Cancer
Studies Lung Cancer
14 reported clinical trials
38 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Brendan Connell is currently running
Tivozanib + Pembrolizumab
for Kidney Cancer
This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Tivozanib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals tumor cells to multiply. This helps stop the spread of tumor cells. Giving pembrolizumab and tivozanib together may work better than pembrolizumab alone in treating patients with RCC.
Recruiting2 awards Phase 37 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
More about Brendan Connell
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Brendan Connell has experience with
- Pembrolizumab
- Darolutamide
- Nivolumab
- Avelumab
- Ipilimumab
- Docetaxel
Breakdown of trials Brendan Connell has run
Prostate Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brendan Connell specialize in?
Brendan Connell focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Brendan Connell currently recruiting for clinical trials?
Yes, Brendan Connell is currently recruiting for 6 clinical trials in Burlington Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Brendan Connell has studied deeply?
Yes, Brendan Connell has studied treatments such as Pembrolizumab, Darolutamide, Nivolumab.
What is the best way to schedule an appointment with Brendan Connell?
Apply for one of the trials that Brendan Connell is conducting.
What is the office address of Brendan Connell?
The office of Brendan Connell is located at: Lahey Hospital and Medical Center, Burlington, Massachusetts 01805 United States. This is the address for their practice at the Lahey Hospital and Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.